Summit Therapeu ADR (SMMT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2023 | 09-2023 | 06-2023 | 03-2023 | 12-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -614,928 | -578,361 | -557,093 | -542,376 | -78,782 |
| Depreciation Amortization | 198 | 168 | 136 | 90 | 2,514 |
| Accounts receivable | 359 | 359 | 356 | 350 | 975 |
| Accounts payable and accrued liabilities | 2,263 | 2,935 | 605 | 308 | -4,132 |
| Other Working Capital | -4,684 | -13,434 | -14,164 | -1,033 | 179 |
| Other Operating Activity | 540,032 | 531,032 | 527,756 | 529,530 | 37,664 |
| Operating Cash Flow | $-76,760 | $-57,301 | $-42,404 | $-13,131 | $-41,582 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -112,857 | -173,427 | -169,994 | -169,995 | N/A |
| PPE Investments | 98 | 100 | 153 | -53 | -624 |
| Other Investing Activity | -475,015 | -475,015 | -475,015 | -475,015 | 0 |
| Investing Cash Flow | $-587,774 | $-648,342 | $-644,856 | $-645,063 | $-624 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | N/A | N/A | 545,000 |
| Common Stock Issued | 110,615 | 104,947 | 105,337 | 105,337 | 100,399 |
| Other Financing Activity | -24,102 | -24,686 | -25,305 | -25,225 | -25,155 |
| Financing Cash Flow | $86,513 | $80,261 | $80,032 | $80,112 | $620,244 |
| Exchange Rate Effect | 839 | 567 | 737 | 444 | -1,222 |
| Beginning Cash Position | 648,607 | 648,607 | 648,607 | 648,607 | 71,791 |
| End Cash Position | 71,425 | 23,792 | 42,116 | 70,969 | 648,607 |
| Net Cash Flow | $-577,182 | $-624,815 | $-606,491 | $-577,638 | $576,816 |
| Free Cash Flow | |||||
| Operating Cash Flow | -76,760 | -57,301 | -42,404 | -13,131 | -41,582 |
| Capital Expenditure | -128 | -126 | -73 | -53 | -624 |
| Free Cash Flow | -76,888 | -57,427 | -42,477 | -13,184 | -42,206 |